Skip to main content
NCBI home page
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 1994 Feb;60(2):387–392. doi: 10.1128/aem.60.2.387-392.1994

Comparative sensitivity of the echovirus type 25 JV-4 prototype strain and two recent isolates to glutaraldehyde at low concentrations.

M Chambon 1, J L Bailly 1, H Peigue-Lafeuille 1
PMCID: PMC201324  PMID: 8135510

Abstract

The sensitivity of two recently isolated antigenic variants of echovirus type 25 (Montpellier 76-1262 and Thionville 86-222) to glutaraldehyde (GTA) at low concentrations was compared with that of the JV-4 prototype strain. The purified viruses were treated under the same conditions with GTA at concentrations ranging from 0.002 to 0.10%. The wild strains exhibited significantly lower sensitivity to GTA than did the prototype strain; with 0.10% GTA, a 2 log10 unit reduction was obtained in 5 min for JV-4 and in 60 and 80 min for Montpellier 76-1262 and Thionville 86-222, respectively. A comparison with previous results obtained with poliovirus type 1 showed that the inactivation rates of echovirus type 25 wild strains were fivefold lower than those of the poliovirus type 1 Sabin strain. The comparative electrophoretic and immunoblot analyses showed differences in the results of GTA binding with capsid proteins of the viruses. Unlike in the poliovirus type 1 Mahoney strain and in the echovirus type 25 JV-4 reference strain, GTA produced only minor intermolecular cross-linkings in the viral particles of the two wild strains of echovirus type 25. Our results suggest that there are both intertypic and intratypic differences in the GTA sensitivities of enterovirus strains. They are of relevance to disinfection procedures in digestive endoscopy and to the choice of the enterovirus strain used for evaluating the efficacy of disinfectants.

Full text

PDF
387

Images in this article

390Image
on p.390
390Image
on p.390

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailly J. L., Chambon M., Peigue-Lafeuille H., Laveran H., De Champs C., Beytout D. Activity of glutaraldehyde at low concentrations (less than 2%) against poliovirus and its relevance to gastrointestinal endoscope disinfection procedures. Appl Environ Microbiol. 1991 Apr;57(4):1156–1160. doi: 10.1128/aem.57.4.1156-1160.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boudouma M., Enjalbert L., Didier J. A simple method for the evaluation of antiseptic and disinfectant virucidal activity. J Virol Methods. 1984 Dec;9(4):271–276. doi: 10.1016/0166-0934(84)90052-1. [DOI] [PubMed] [Google Scholar]
  3. Chambon M., Bailly J. L., Peigue-Lafeuille H. Activity of glutaraldehyde at low concentrations against capsid proteins of poliovirus type 1 and echovirus type 25. Appl Environ Microbiol. 1992 Nov;58(11):3517–3521. doi: 10.1128/aem.58.11.3517-3521.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Drulak M., Wallbank A. M., Lebtag I. The relative effectiveness of commonly used disinfectants in inactivation of echovirus 11. J Hyg (Lond) 1978 Aug;81(1):77–87. doi: 10.1017/s002217240005378x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Drulak M., Wallbank A. M., Lebtag I., Werboski L., Poffenroth L. The relative effectiveness of commonly used disinfectants in inactivation of coxsackievirus B5. J Hyg (Lond) 1978 Dec;81(3):389–397. doi: 10.1017/s0022172400025274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HIATT C. W. KINETICS OF THE INACTIVATION OF VIRUSES. Bacteriol Rev. 1964 Jun;28:150–163. doi: 10.1128/br.28.2.150-163.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harmenberg J., Wahren B., Sundqvist V. A., Levén B. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds. J Antimicrob Chemother. 1985 May;15(5):567–573. doi: 10.1093/jac/15.5.567. [DOI] [PubMed] [Google Scholar]
  8. Heinz B. A., Rueckert R. R., Shepard D. A., Dutko F. J., McKinlay M. A., Fancher M., Rossmann M. G., Badger J., Smith T. J. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J Virol. 1989 Jun;63(6):2476–2485. doi: 10.1128/jvi.63.6.2476-2485.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kew O. M., Nottay B. K., Hatch M. H., Nakano J. H., Obijeski J. F. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol. 1981 Oct;56(Pt 2):337–347. doi: 10.1099/0022-1317-56-2-337. [DOI] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  12. Minor P. D., Schild G. C., Ferguson M., Mackay A., Magrath D. I., John A., Yates J. P., Spitz M. Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping. J Gen Virol. 1982 Aug;61(Pt 2):167–176. doi: 10.1099/0022-1317-61-2-167. [DOI] [PubMed] [Google Scholar]
  13. Narang H. K., Codd A. A. Action of commonly used disinfectants against enteroviruses. J Hosp Infect. 1983 Jun;4(2):209–212. doi: 10.1016/0195-6701(83)90052-x. [DOI] [PubMed] [Google Scholar]
  14. Nottay B. K., Kew O. M., Hatch M. H., Heyward J. T., Obijeski J. F. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology. 1981 Jan 30;108(2):405–423. doi: 10.1016/0042-6822(81)90448-7. [DOI] [PubMed] [Google Scholar]
  15. Peigue-Lafeuille H., Bailly J. L., Aymard M., Fuchs F. Use of non-neutralizing monoclonal antibodies in an ELISA for intratypic differentiation of 28 echovirus type 25 clinical isolates. J Virol Methods. 1992 Jan;36(1):91–99. doi: 10.1016/0166-0934(92)90160-f. [DOI] [PubMed] [Google Scholar]
  16. Peigue-Lafeuille H., Bailly J. L., Fuchs F., Chambon M., Aymard M. Heterogeneity of capsid proteins of echovirus type 25 wild-type strain and prototype strain, studied by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. J Clin Microbiol. 1991 Sep;29(9):1780–1784. doi: 10.1128/jcm.29.9.1780-1784.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Peigue-Lafeuille H., Fuchs F., Gharabaghi F., Chambon M., Aymard M. Impact on routine diagnosis of echovirus infections of intratypic differentiation and antigenic variation in echovirus type 25 studied by using monoclonal antibodies. J Clin Microbiol. 1990 Oct;28(10):2291–2296. doi: 10.1128/jcm.28.10.2291-2296.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Prabhakar B. S., Haspel M. V., McClintock P. R., Notkins A. L. High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies. Nature. 1982 Nov 25;300(5890):374–376. doi: 10.1038/300374a0. [DOI] [PubMed] [Google Scholar]
  19. Quero A. M., Daireaux M. D., Fontanges R., Beaudry M. Y., Laine G. Détermination de l'activité virucide des antiseptiques par une méthode de filtration sur gel. Pathol Biol (Paris) 1984 Jun;32(5 Pt 2):636–639. [PubMed] [Google Scholar]
  20. Saitanu K., Lund E. Inactivation of enterovirus by glutaraldehyde. Appl Microbiol. 1975 May;29(5):571–574. doi: 10.1128/am.29.5.571-574.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sattar S. A., Springthorpe V. S., Karim Y., Loro P. Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol Infect. 1989 Jun;102(3):493–505. doi: 10.1017/s0950268800030211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tyler R., Ayliffe G. A., Bradley C. Virucidal activity of disinfectants: studies with the poliovirus. J Hosp Infect. 1990 May;15(4):339–345. doi: 10.1016/0195-6701(90)90090-b. [DOI] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES